Myocardial Protection
10
0
0
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
20%
2 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
Comparison of Changes in Intra-myocardial Amino Acids During Use of Calafiore and Modified Del Nido Cardioplegia
Effect of the Addition of Adenosine on Myocardial Protection During Cardiopulmonary Bypass
Impact of Different Cardioplegia Solutions on Indicators of Myocardial Injury During Coronary Surgery
Effects of TENS on Myocardial Protection in Patients Undergoing AVR
Myocardial Protection in Minimally Invasive Mitral Valve Surgery
Protection of the Heart With Remote Ischemic Preconditioning During Heart Surgery: A Pilot Study
Myocardial Biopsy in Congenital Cardiac Surgery
Comparison of Blood and Crystalloid Cardioplegia
Comparison of Blood Cardioplegia and Custodiol
Levosimendan and Myocardial Protection